1. Home
  2. TRAK vs MDWD Comparison

TRAK vs MDWD Comparison

Compare TRAK & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRAK

ReposiTrak Inc.

N/A

Current Price

$7.67

Market Cap

157.2M

Sector

Technology

ML Signal

N/A

Logo MediWound Ltd.

MDWD

MediWound Ltd.

N/A

Current Price

$12.27

Market Cap

162.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TRAK
MDWD
Founded
1990
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
157.2M
162.2M
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
TRAK
MDWD
Price
$7.67
$12.27
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $30.67
AVG Volume (30 Days)
★ 69.0K
62.5K
Earning Date
11-12-2026
11-19-2026
Dividend Yield
★ 1.04%
N/A
EPS Growth
★ 11.43
N/A
EPS
★ 0.39
N/A
Revenue
★ $21,007,076.00
N/A
Revenue This Year
$9.50
$39.60
Revenue Next Year
$10.00
$34.34
P/E Ratio
$19.64
★ N/A
Revenue Growth
★ 4.84
N/A
52 Week Low
$6.94
$12.19
52 Week High
$15.80
$20.03

Technical Indicators

Market Signals
Indicator
TRAK
MDWD
Relative Strength Index (RSI) 32.02 31.48
Support Level $7.50 N/A
Resistance Level $8.53 $14.06
Average True Range (ATR) 0.25 0.38
MACD -0.06 -0.15
Stochastic Oscillator 1.05 0.00

Price Performance

Historical Comparison
TRAK
MDWD

About TRAK ReposiTrak Inc.

ReposiTrak Inc is a software-as-a-service (SaaS) company based in Murray, Utah, specializing in supply chain management solutions for retailers, suppliers, and wholesalers, prominently in the food industry. The company offers three main product suites: ReposiTrak Compliance Management, ReposiTrak Traceability Network, and ReposiTrak Supply Chain Solutions. These platforms help customers comply with food safety regulations, manage supplier compliance documentation, trace products through the supply chain, and optimize supply chain operations. The company derives revenue from five sources: (i) subscription fees, (ii) transaction-based fees, (iii) professional services fees, (iv) license fees, and (v) hosting and maintenance fees.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: